Riskpilot← Back to searchSign inGet full accessMakMedic AB
ABActiveOrg 5590059100Bergmästaregatan 16 CHospital activities · NACE 8610Est. 20151 employees
Revenue 2025
SEK 1,5M
-29% vs 2024
EBITDA margin
18.1%
-72% vs 2024
Equity ratio
70.9%
Financial strength
Net profit 2025
SEK 59K
-90% vs 2024
| Revenue | SEK 1,5M | -29% |
| EBITDA | SEK 265K | -72% |
| Net profit | SEK 59K | -90% |
| Total assets | SEK 5,5M | +5% |
| Equity | SEK 3,9M | +2% |
| Employees | 1 | — |
Legal name
MakMedic AB
Org number
5590059100
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
2 mars 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva läkarbemanning inom primärvård samt specialiserad sjukhusvård samt skönhetsbehandlingar såsom ansikts- och injektionsbehandlingar och därmed förenlig verksamhet.
Address
Bergmästaregatan 16 C
Email
amir.makanvand@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 016 | 2 361 | 1 367 | 2 067 | 1 462 |
| Staff expenses | — | — | — | — | −26 |
| EBITDA | 1 167 | 1 550 | 439 | 954 | 265 |
| Depreciation & amort. | −0 | −0 | −0 | −142 | −131 |
| EBIT | 1 167 | 1 550 | 439 | 812 | 134 |
| Net financials | −1 | — | — | −67 | −55 |
| Profit before tax | 1 166 | 1 551 | 439 | 745 | 79 |
| Tax | −255 | −323 | −95 | −159 | −20 |
| Net profit | 911 | 1 228 | 344 | 586 | 59 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 828 | 4 275 | 3 953 | 5 273 | 5 539 |
| Equity | 2 111 | 3 338 | 3 479 | 3 870 | 3 929 |
| Long-term debt | 0 | 0 | 0 | 1 343 | 1 328 |
| Short-term debt | 717 | 937 | 474 | 61 | 282 |
| Total debt | 717 | 937 | 474 | 1 404 | 1 611 |
EBITDA margin
18.1%
This company
15.8%
Market median
+15% vs market
20212025
Equity ratio
70.9%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
1.5%
This company
18.4%
Market median
-92% vs market
20212025
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
20212025
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MakMedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Baback Karimi | Deputy Board Member | 0 companies |
| Anna Belinda Wermelin | Deputy Board Member | 0 companies |
| Amir Makanvand | Board of Directors | 0 companies |